Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$58.53 - $68.82 $6,438 - $7,570
-110 Reduced 0.94%
11,615 $739,000
Q3 2023

Nov 13, 2023

SELL
$50.28 - $64.61 $754 - $969
-15 Reduced 0.13%
11,725 $680,000
Q2 2023

Aug 11, 2023

BUY
$37.29 - $53.83 $20,845 - $30,090
559 Added 5.0%
11,740 $631,000
Q1 2023

May 11, 2023

BUY
$37.61 - $45.72 $420,517 - $511,195
11,181 New
11,181 $444,000
Q3 2021

Nov 15, 2021

SELL
$26.48 - $35.99 $974,940 - $1.33 Million
-36,818 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$31.86 - $38.6 $1.17 Million - $1.42 Million
36,818 New
36,818 $1.29 Million
Q1 2021

May 13, 2021

SELL
$28.4 - $36.14 $264,546 - $336,644
-9,315 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$23.69 - $31.47 $220,672 - $293,143
9,315 New
9,315 $574,000
Q2 2020

Aug 13, 2020

SELL
$29.93 - $50.1 $190,384 - $318,686
-6,361 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$30.35 - $67.14 $143,069 - $316,497
-4,714 Reduced 42.56%
6,361 $259,000
Q4 2019

Feb 14, 2020

SELL
$55.65 - $79.83 $5,565 - $7,983
-100 Reduced 0.89%
11,075 $683,000
Q3 2019

Nov 14, 2019

SELL
$64.7 - $85.39 $881,861 - $1.16 Million
-13,630 Reduced 54.95%
11,175 $814,000
Q2 2019

Aug 14, 2019

SELL
$67.77 - $82.2 $201,615 - $244,545
-2,975 Reduced 10.71%
24,805 $2.04 Million
Q1 2019

May 15, 2019

SELL
$45.83 - $70.54 $53,850 - $82,884
-1,175 Reduced 4.06%
27,780 $1.96 Million
Q4 2018

Feb 14, 2019

SELL
$41.17 - $56.44 $33,141 - $45,434
-805 Reduced 2.7%
28,955 $1.3 Million
Q3 2018

Nov 14, 2018

BUY
$52.95 - $71.34 $248,070 - $334,227
4,685 Added 18.68%
29,760 $1.68 Million
Q2 2018

Aug 14, 2018

SELL
$56.38 - $68.08 $46,513 - $56,166
-825 Reduced 3.19%
25,075 $1.68 Million
Q1 2018

May 15, 2018

BUY
$56.98 - $72.41 $834,757 - $1.06 Million
14,650 Added 130.22%
25,900 $1.51 Million
Q4 2017

Feb 14, 2018

BUY
$53.3 - $74.56 $599,625 - $838,800
11,250
11,250 $725,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $973M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.